Replies to post #369 on Novartis (NVS)

[Ecomike]

Higher PE sounds sweet :-)

But if Alcon was an earnings dog, why did the stock price go into orbit 150% and NVS got hammered by about an extra $15 after it gave up Alcon??

The lower price and no reduction in the dividend, and stock buy back and CEO forward guidance all look like a buy down this low.

Is the MS Drug news a good thing or way down the pike?

I am catching up all the news right now, still reading....

I would think that the NVS balance sheet might have shed some Alcon long term liabilities and debt?